STOCK TITAN

Cutera, Inc. Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

Cutera, a leader in aesthetic and dermatology solutions, announced the granting of 44,500 non-qualified inducement stock options to six employees.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

BRISBANE, Calif.--(BUSINESS WIRE)-- Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, granted a total of 44,500 non-qualified inducement stock options to six employees. These awards were approved by the Compensation Committee of Cutera’s Board of Directors.

The stock options have an exercise price of $2.23, equal to the closing price of Cutera common stock on the grant date of May 13, 2024. A quantity of 25% shall vest annually, and 1/48 of the grant total shall vest each month thereafter, subject to continued employment, for a total of 29,500 stock options granted to five employees. A quantity of 33% shall vest annually, and 1/36 of the grant total shall vest each month thereafter, subject to continued employment, for a total of 15,000 stock options granted to one employee.

Each inducement award is subject to the terms of the Cutera, Inc. 2023 Inducement Equity Incentive Plan and related forms of agreements and were granted as inducements material to these employees to enter into employment with Cutera in accordance with Nasdaq Listing Rule 5635(c)(4).

About Cutera, Inc.

Cutera is a leading provider of aesthetic and dermatology solutions for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that harness the power of science and nature to enable medical practitioners to offer safe and effective treatments to their patients. For more information, call +1-415-657-5500 or 1-888-4CUTERA or visit www.cutera.com.

Cutera, Inc.
Shelby Eckerman
VP, Finance
415-657-5500
IR@cutera.com

Source: Cutera, Inc.

Keep reading